This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
n11http://dx.doi.org/10.1136/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q60729390
rdf:type
wikibase:Item
schema:description
im Mai 2012 veröffentlichter wissenschaftlicher Artikel bài báo khoa học wetenschappelijk artikel scientific article published on 14 May 2012 наукова стаття, опублікована в травні 2012 artículu científicu espublizáu en mayu de 2012
p:P577
wds:Q60729390-B6BEAB55-518B-41DB-8DC8-8FB5D89FA067
wdt:P577
2012-05-14T00:00:00Z
p:P407
wds:Q60729390-1C40659E-A31D-4E49-A23D-9415E87DE07B
wdt:P407
wd:Q1860
p:P2093
wds:Q60729390-024D38CA-46F4-4271-9F0E-9546137FFF3C wds:Q60729390-EA1BF2B8-8DB6-4536-B126-2D48C3081DFD wds:Q60729390-D5701959-19E4-4788-9C71-E2CC0C67391A wds:Q60729390-4FE4F89C-F133-46ED-AA8B-9C097A8A33D3
wdt:P2093
Luigi Sinigaglia Beniamina Gallelli Renato Alberto Sinico Giulio Romano
rdfs:label
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
skos:prefLabel
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
schema:name
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
p:P50
wds:Q60729390-81C3E751-86FA-4460-8378-60A0A90999AE wds:Q60729390-AF4AE182-F5C2-4682-9314-4D91DBB53B92
wdt:P50
wd:Q87983056 wd:Q46463588
p:P1476
wds:Q60729390-70D7FB21-74F7-4CA2-B98C-C21D0C630C7B
wdt:P1476
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
p:P304
wds:Q60729390-D415F112-1DD5-4E4B-8FC1-297A8D6AA8C5
wdt:P304
1751-1752
p:P31
wds:Q60729390-7A7CB27C-6A58-4C30-A2DB-E6BBF080A0E9
wdt:P31
wd:Q13442814
p:P921
wds:Q60729390-A4DB3CCD-60BA-4D15-A867-623480070EC3 wds:Q60729390-514B59E0-2BA1-4D2C-9518-396D6568A6EF
wdt:P921
wd:Q1621830 wd:Q412323
p:P698
wds:Q60729390-8FEB0B4F-05E2-4C3E-B1E3-BE0BCECCBD15
wdtn:P698
n10:22586177
wdt:P698
22586177
p:P1433
wds:Q60729390-2B555991-F143-425C-992D-200C54E897D3
wdt:P1433
wd:Q4767876
p:P433
wds:Q60729390-3BBBBD67-463E-4F8B-9B3E-F5A69BC21E35
p:P478
wds:Q60729390-AEBA8540-F4D6-46B4-8F0C-C498B3A007B8
wdt:P433
10
wdt:P478
71
p:P356
wds:Q60729390-D5103B85-A5CE-4D17-A352-A951986B1C66
wdtn:P356
n11:ANNRHEUMDIS-2012-201442
wdt:P356
10.1136/ANNRHEUMDIS-2012-201442